Operating Lease, Right-of-Use Asset of SUPERNUS PHARMACEUTICALS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $28,761,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $28,761,000 +$2,675,000 +10% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $21,881,000 -$5,885,000 -21% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $22,724,000 -$7,024,000 -24% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $24,477,000 -$4,517,000 -16% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $26,086,000 -$3,370,000 -11% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $27,766,000 -$1,379,000 -4.7% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $29,748,000 -$274,000 -0.91% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $28,994,000 +$90,000 +0.31% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $29,456,000 -$207,000 -0.7% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $29,145,000 -$1,491,000 -4.9% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $30,022,000 -$2,119,000 -6.6% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $28,904,000 -$6,461,000 -18% 31 Dec 2022 10-Q 08 Nov 2023 2023 Q3
Q3 2022 $29,663,000 -$445,000 -1.5% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $30,636,000 +$971,000 +3.3% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $32,141,000 +$11,333,000 +54% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $35,365,000 +$15,134,000 +75% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $30,108,000 +$9,089,000 +43% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $29,665,000 +$8,376,000 +39% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $20,808,000 -$1,103,000 -5% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $20,231,000 -$1,048,000 -4.9% 31 Dec 2020 10-K 13 Apr 2022 2021 FY
Q3 2020 $21,019,000 +$2,239,000 +12% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $21,289,000 +$1,650,000 +8.4% 30 Jun 2020 10-Q 17 Aug 2020 2020 Q2
Q1 2020 $21,911,000 +$1,862,000 +9.3% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $21,279,000 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 $18,780,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $19,639,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $20,049,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.